Quick facts
- Health Canada states that a personal care product can be regulated as a cosmetic or a drug depending on its ingredients and claims, and that it is legally classified as a drug if it makes claims to modify body functions, or to prevent or treat disease.
- The Canadian definition turns on the words used to sell the product, not on the shape of the patch. A patch sold to moisturise the skin under the eye and a patch sold to repair a condition can sit on different legal routes.
- In the United States the same split exists: a product intended to cleanse, beautify or alter appearance is a cosmetic, while one intended to treat or prevent disease or affect the structure or function of the body is a drug, and a product can be both.
- A cosmetic sold in Canada carries labelling duties under the Cosmetic Regulations, including an ingredient list and dealer information, and the establishment notifies the product through the Cosmetic Notification Form.
- A drug route brings a different set of obligations, including a Drug Identification Number or Natural Product Number where applicable, and drug labelling rather than cosmetic labelling.
- The Health Canada and FDA texts were read on 2026-10-19. This article describes the regulatory test; it does not classify any specific product.
An under-eye patch is a small piece of absorbent material worn under the eye for ten to thirty minutes, and it is sold in two very different registers: as a cosmetic that improves the look of the skin, and as a product that changes what the skin is doing. The distinction is not academic. In Canada it decides whether the pack carries a cosmetic label or a drug label, and in the United States it decides whether the pack needs Drug Facts. This article sets out the test both regulators apply, the claim sentences that move a product from one route to the other, and the label elements a clinic or retailer should be able to check before stocking; the eye-area compress we list is a
USB heated eye mask, a device rather than either category, which is a useful third example of how the route follows the claim.
What is an under-eye patch, and what is it claimed to do?
Physically it is a patch of hydrogel, cotton or non-woven fabric, often impregnated with humectants, peptides, caffeine or botanical extracts, cut to sit on the infraorbital skin. It is left in place for a short period and then discarded. The form is trivial; the marketing sentence is not.
The claims cluster into three groups. The first is appearance: moisturises, refreshes, temporarily plumps, reduces the look of dryness. The second is sensation: cools, soothes, depuffs after sleep. The third is function or therapy: repairs the barrier, treats dermatitis, reduces inflammation, removes dark circles caused by a condition. The first two groups normally read as cosmetic; the third moves toward drug territory, and the exact wording decides.
The same physical patch can be sold under any of the three, which is why two products that look identical on a shelf can carry different labels. The manufacturer chooses the claim, and the claim chooses the regulatory route.
How does Canada decide whether a patch is a cosmetic or a drug?
Health Canada's consumer guidance is short and worth quoting in full because it is the test a buyer can actually apply: a beauty product or grooming aid is usually a cosmetic, but is legally classified as a drug if it makes any claims to modify body functions, or to prevent or treat disease. The Food and Drugs Act supplies the statutory definitions behind that sentence, and the Cosmetic Regulations supply the labelling and notification duties for the cosmetic route.
For a cosmetic, the obligations are mostly about disclosure and safety: an ingredient list in the required format, the name and address of the dealer, and notification of the product and its ingredients through the Cosmetic Notification Form. The ingredients are also screened against the Cosmetic Ingredient Hotlist, which lists substances that are prohibited or restricted in cosmetic products.
For a drug, the obligations shift to pre-market authorisation and to drug labelling. A product that claims to treat a disease or to modify a body function is no longer being sold as a cosmetic, even if the box looks like skincare. The practical consequence for a clinic retailer is that the same shelf position can hold two products with different compliance files.
| Claim on the pack | Canada, ordinary reading | United States, ordinary reading |
|---|---|---|
| Moisturises the skin under the eye | Cosmetic | Cosmetic |
| Temporarily reduces the look of puffiness | Cosmetic, if the effect is presented as appearance | Cosmetic, if appearance only |
| Cools and soothes tired eyes | Cosmetic | Cosmetic |
| Repairs the skin barrier | Borderline; wording decides | Borderline; structure or function claim |
| Treats dermatitis or an eye condition | Drug | Drug |
| Removes dark circles caused by disease | Drug | Drug |
| Product sold with both cosmetic and therapeutic claims | Drug route for the therapeutic claim | Drug and cosmetic, with both labelling sets |
What is the American test?
The FDA draws the same line with different words: cosmetics are articles intended to be rubbed, poured, sprinkled or sprayed on, introduced into or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness or altering appearance, while drugs are articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, or intended to affect the structure or any function of the body.
The labelling follows the category. A cosmetic carries the cosmetic label elements under 21 CFR 701.3, including a declaration of ingredients in descending order of predominance. A drug carries Drug Facts under 21 CFR 201.66, with active ingredients, purposes, uses, warnings, directions and the other required panels. A product that is both carries both.
The American system is often described as claim-based, and it is, but the claim is read together with the product's intended use, which can be established by labelling, advertising, website copy and even oral statements. A patch marketed with before-and-after photographs and the sentence 'reduces puffiness' can be a cosmetic; the same patch with 'treats periorbital oedema' is a drug.
Which claim sentences should a buyer look for?
Read the front of the pack, the back of the pack and the product page separately, because they are often written by different people and do not always agree. The front tends to carry the appearance claim, the back carries the directions, and the product page carries the sentence that creates the most legal exposure.
The sentences that move a product toward the drug route are those that name a condition, promise a physiological change, or use the vocabulary of treatment: repairs, heals, treats, cures, prevents, reduces inflammation, restores the barrier, corrects pigmentation. The sentences that keep it on the cosmetic route describe appearance and sensation: moisturises, softens, refreshes, cools, temporarily reduces the look of.
There is no list of approved sentences. The test is the meaning conveyed to the ordinary consumer, which is why two phrases that look similar to a copywriter can look different to a regulator. When the claim sits on the line, the safer commercial decision is to rewrite the claim rather than to argue about it after the product is on the shelf.
What must the label carry on each route?
On the Canadian cosmetic route, the label needs the ingredient list, the dealer's name and address, and the product identity, with the ingredient disclosure rules in the Cosmetic Regulations. The product also needs to be notified, and the notification is tied to the ingredients and the product identity rather than to the marketing copy alone.
On the Canadian drug route, the label follows drug requirements, including a Drug Identification Number or Natural Product Number where the product falls under those schemes, and the accompanying information has to support the claim. The switch is not a matter of adding a sentence; it changes the pre-market file.
On the American side, the cosmetic label and the Drug Facts panel are separate layouts, and a dual product carries both. A retailer checking a shipment can therefore learn a great deal from the pack itself: if the pack has Drug Facts, the supplier has taken the drug route in the United States, and the Canadian file should be consistent with that positioning.
| Element | Canadian cosmetic | Canadian drug | US cosmetic | US drug |
|---|---|---|---|---|
| Ingredient disclosure | Required, per regulations | Drug labelling rules | 21 CFR 701.3 | Drug Facts |
| Market authorisation | Notification (CNF) | DIN or NPN where applicable | No pre-market approval | Approval or monograph route |
| Claim test | Appearance and beautifying | Treat, prevent, modify function | Appearance | Disease or structure/function |
| Typical pack signal | Cosmetic label | Drug label | Cosmetic label | Drug Facts panel |
What does this mean for an optometry or aesthetics clinic?
The clinic is not the manufacturer, but it is the party the patient sees, and it may be the party whose name is on the shelf talker. Two controls are worth having. First, keep the supplier's claim sheet and the pack copy on file, so that the claim being made in the clinic matches the claim the product was authorised under. Second, do not add clinical language in the clinic's own materials that the pack does not support.
The Competition Act adds a separate layer: representations to the public must not be materially false or deceptive, and that applies to the clinic's own advertising as well as the manufacturer's. A display card that promises to remove dark circles is a representation, whatever the pack says.
For a clinic that sells both cosmetic patches and a device such as a moist heat compress, the cleanest internal rule is to keep the categories separate in the purchasing file and in the staff script. The customer question 'what does this do?' should be answered with the claim the product is allowed to make, not with the outcome the clinician has seen in practice.
A clinic retail shelf also carries eye-area devices that sit outside the cosmetic and drug categories. Order through the wholesale programme for case pricing and an account, or become a distributor for resale. The USB heated eye mask sits in the same catalogue.
Sources
- Health Canada, What is a cosmetic?
- Cosmetic Regulations, C.R.C., c. 869
- Food and Drugs Act, R.S.C., 1985, c. F-27
- Competition Act, R.S.C., 1985, c. C-34
- Health Canada, cosmetic ingredient hotlist
- Health Canada, medical devices
- Health Canada, establishment licensing
- Medical Devices Regulations, SOR/98-282
- 21 CFR 701.3, designation of ingredients
- 21 CFR 201.66, format and content requirements for over-the-counter drug product labels
- openFDA device classification API
- FDA product classification database
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, application of risk management to medical devices
- Canadian Association of Optometrists
- Canadian Ophthalmological Society
- Public Health Ontario, infection prevention and control
- CSA Group, standards catalogue
Printable claim-check sheet. Before a patch goes on the shelf, put the pack claim, the product page claim and the supplier's authorisation side by side. Print a product claim review sheet - three columns, one row per SKU, with a signature line for the person who checked the wording; it prints with no account and no sign-up.
Log generator. Turn the review into a dated schedule so that revised packs and revised web copy are re-checked rather than remembered. Build a product review calendar - the page lays out the months and the fields an audit reads, from SKU to action taken.
Ask a compliance specialist. Whether a specific under-eye claim is cosmetic or drug in Canada depends on the sentence and the context, not on the category name. Ask a compliance specialist - written answer specific to your product and province, with the regulation or standard it is based on cited.
Related reading
- Teeth whitening products in Canada and the US: which standards apply
- Eye exam charts in Canada and the US: which rules apply
- Ophthalmic eye shields in Canada and the US: which device rules apply
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for clinic and retail buyers and is not legal advice; whether a particular product is a cosmetic or a drug is decided by its claims, its ingredients and the regulator's reading of them.
Frequently Asked Questions
Is an under-eye patch a cosmetic or a drug in Canada?
It depends on the claim. Health Canada classifies a product as a drug if it claims to modify body functions or to prevent or treat disease. A patch sold to moisturise or refresh the appearance is normally a cosmetic; one sold to treat a condition is a drug.
What is the test Health Canada applies?
Health Canada states that a personal care product can be regulated as a cosmetic or a drug depending on its ingredients and claims, and that it is legally classified as a drug if it makes any claims to modify body functions, or to prevent or treat disease.
Does the same split exist in the United States?
Yes. A cosmetic is intended to cleanse, beautify or alter appearance; a drug is intended to treat or prevent disease or to affect the structure or function of the body. A product can be both, and then carries both cosmetic labelling and Drug Facts.
Which words push a patch toward the drug route?
Words that name a condition or promise a physiological change: treats, heals, repairs the barrier, reduces inflammation, restores, corrects pigmentation. Appearance and sensation words - moisturises, cools, temporarily reduces the look of - normally stay on the cosmetic side.
What labelling does a Canadian cosmetic need?
The Cosmetic Regulations require an ingredient list and dealer information, and the product is notified through the Cosmetic Notification Form. Ingredients are also screened against the Cosmetic Ingredient Hotlist.
Can a clinic change the claim on its own display material?
It can, but it then owns the representation. The Competition Act prohibits representations to the public that are materially false or deceptive, so clinic copy should stay within the claim the product is authorised to make.